Rathbones Group PLC Abbott Laboratories Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Rathbones Group PLC holds 2,541,806 shares of ABT stock, worth $292 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares

2,541,806

Previous 2,507,626 1.36%

Holding current value

$292 Million

Previous $261 Million 11.22%

% of portfolio

1.52%

Previous 1.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $3.42 Million - $4.04 Million	34,180 Added 1.36%	2,541,806 $290 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $12.9 Million - $14.4 Million	128,252 Added 5.39%	2,507,626 $261 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $12.7 Million - $14 Million	115,640 Added 5.11%	2,379,374 $270 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $11.4 Million - $13.9 Million	126,160 Added 5.9%	2,263,734 $249 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $17.6 Million - $21.1 Million	183,803 Added 9.41%	2,137,574 $207 Million
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $11.3 Million - $12.5 Million	111,710 Added 6.06%	1,953,771 $213 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $8.88 Million - $10.5 Million	91,668 Added 5.24%	1,842,061 $187 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $343,546 - $403,033	3,614 Added 0.21%	1,750,393 $192 Million
Q3 2022 Nov 03, 2022	BUY	$96.76 - $112.03 $6.5 Million - $7.53 Million	67,199 Added 4.0%	1,746,779 $169 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $4.3 Million - $5.2 Million	42,119 Added 2.57%	1,679,580 $182 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $7.53 Million - $9.18 Million	-66,026 Reduced 3.88%	1,637,461 $194 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $9.34 Million - $11.4 Million	80,835 Added 4.98%	1,703,487 $240 Million
Q3 2021 Nov 04, 2021	BUY	$116.66 - $129.06 $5.57 Million - $6.16 Million	47,732 Added 3.03%	1,622,652 $192 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $15.5 Million - $18.3 Million	146,958 Added 10.29%	1,574,920 $183 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $23.3 Million - $27.5 Million	214,300 Added 17.66%	1,427,962 $171 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $9.73 Million - $10.6 Million	92,638 Added 8.26%	1,213,662 $133 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $5.89 Million - $7.16 Million	64,314 Added 6.09%	1,121,024 $122 Million
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $15.6 Million - $20 Million	203,815 Added 23.9%	1,056,710 $96.6 Million
Q1 2020 May 04, 2020	BUY	$62.82 - $91.86 $12 Million - $17.5 Million	190,357 Added 28.73%	852,895 $67.3 Million
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $5.16 Million - $5.75 Million	65,753 Added 11.02%	662,538 $57.5 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $12.4 Million - $13.4 Million	151,226 Added 33.94%	596,785 $49.9 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $3.85 Million - $4.49 Million	52,874 Added 13.46%	445,559 $37.5 Million
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $1.69 Million - $2.04 Million	25,492 Added 6.94%	392,685 $31.4 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $13.1 Million - $14.9 Million	200,540 Added 120.33%	367,193 $26.6 Million
Q3 2018 Oct 12, 2018	SELL	$60.81 - $73.36 $1.03 Million - $1.25 Million	-17,004 Reduced 9.26%	166,653 $12.2 Million
Q2 2018 Jul 16, 2018	SELL	$57.57 - $63.54 $1.51 Million - $1.67 Million	-26,258 Reduced 12.51%	183,657 $11.2 Million
Q1 2018 Apr 06, 2018	SELL	$56.27 - $63.62 $104,943 - $118,651	-1,865 Reduced 0.88%	209,915 $12.6 Million
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $411,457 - $440,507	-7,665 Reduced 3.49%	211,780 $12.1 Million
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $10.5 Million - $11.8 Million	219,445	219,445 $11.7 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Abbott Laboratories Transaction History